Trial Outcomes & Findings for Teaching Obesity Treatment Options to Adult Learners Trial (NCT NCT03856320)

NCT ID: NCT03856320

Last Updated: 2023-07-25

Results Overview

The proportion of patients who were contacted by the study team who also consented and provided baseline assessment data.

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 42 participants
• Primary outcome timeframe: 1 year
• Results posted on: 2023-07-25

Participant Flow

Participant milestones

Measure	Usual Care Patient attends a MOVE! visit (weight management visit).	Intervention Patient attends a MOVE! visit (weight management visit) and watches an educational video describing obesity treatment options available in the VA. Educational Video: An educational video describing obesity treatment options available in the VA.
Overall Study STARTED	20	22
Overall Study COMPLETED	20	20
Overall Study NOT COMPLETED	0	2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Teaching Obesity Treatment Options to Adult Learners Trial

Baseline characteristics by cohort

Measure	Usual Care n=20 Participants Patient attends a MOVE! visit (weight management visit).	Intervention n=22 Participants Patient attends a MOVE! visit (weight management visit) and watches an educational video describing obesity treatment options available in the VA. Educational Video: An educational video describing obesity treatment options available in the VA.	Total n=42 Participants Total of all reporting groups
Age, Continuous	57.5 years STANDARD_DEVIATION 13.1 • n=5 Participants	60.7 years STANDARD_DEVIATION 10.9 • n=7 Participants	59.2 years STANDARD_DEVIATION 11.9 • n=5 Participants
Sex: Female, Male Female	2 Participants n=5 Participants	5 Participants n=7 Participants	7 Participants n=5 Participants
Sex: Female, Male Male	18 Participants n=5 Participants	17 Participants n=7 Participants	35 Participants n=5 Participants
Race/Ethnicity, Customized White, non-Hispanic	18 Participants n=5 Participants	19 Participants n=7 Participants	37 Participants n=5 Participants
Race/Ethnicity, Customized Black, non-Hispanic	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race/Ethnicity, Customized Hispanic	0 Participants n=5 Participants	1 Participants n=7 Participants	1 Participants n=5 Participants
Race/Ethnicity, Customized Other	2 Participants n=5 Participants	2 Participants n=7 Participants	4 Participants n=5 Participants
Region of Enrollment United States	20 participants n=5 Participants	22 participants n=7 Participants	42 participants n=5 Participants
BMI	40.7 kg/m^2 STANDARD_DEVIATION 7.8 • n=5 Participants	43.1 kg/m^2 STANDARD_DEVIATION 5.3 • n=7 Participants	41.9 kg/m^2 STANDARD_DEVIATION 6.6 • n=5 Participants

PRIMARY outcome

Timeframe: 1 year

The proportion of patients who were contacted by the study team who also consented and provided baseline assessment data.

Outcome measures

Measure	All Attempted Recruitment n=89 Participants \# of participants randomized to the study divided by # of participants sent a recruitment letter
Recruitment	42 Participants

PRIMARY outcome

Timeframe: 7-14 days

The proportion of patients who consented and completed the baseline assessment who also completed the post assessment.

Outcome measures

Measure	All Attempted Recruitment n=42 Participants \# of participants randomized to the study divided by # of participants sent a recruitment letter
Retention	40 Participants

Adverse Events

Usual Care

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Intervention

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Luke Funk

William S. Middleton VA Hospital

Phone: 608-256-1901

Email: Luke.Funk@va.gov

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place